Ben Sprangers

8.7k total citations
175 papers, 4.3k citations indexed

About

Ben Sprangers is a scholar working on Nephrology, Transplantation and Surgery. According to data from OpenAlex, Ben Sprangers has authored 175 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Nephrology, 47 papers in Transplantation and 40 papers in Surgery. Recurrent topics in Ben Sprangers's work include Renal Transplantation Outcomes and Treatments (47 papers), Renal Diseases and Glomerulopathies (35 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Ben Sprangers is often cited by papers focused on Renal Transplantation Outcomes and Treatments (47 papers), Renal Diseases and Glomerulopathies (35 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Ben Sprangers collaborates with scholars based in Belgium, United States and Netherlands. Ben Sprangers's co-authors include Dirk Kuypers, Maarten Naesens, Evelyne Lerut, Pieter Evenepoel, Björn Meijers, Kathleen Claes, Bert Bammens, Marie‐Paule Emonds, Maarten Coemans and Aleksandar Senev and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ben Sprangers

167 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Sprangers Belgium 38 1.6k 1.3k 1.2k 878 700 175 4.3k
Marion Rabant France 32 1.8k 1.1× 991 0.8× 1.2k 1.0× 659 0.8× 429 0.6× 147 3.6k
Kazunari Tanabe Japan 40 1.6k 1.0× 872 0.7× 1.9k 1.6× 951 1.1× 1.7k 2.4× 376 5.6k
Bernd Schröppel United States 35 1.2k 0.8× 641 0.5× 1.3k 1.1× 1.1k 1.2× 370 0.5× 96 3.4k
Kazuharu Uchida Japan 30 1.6k 1.0× 1.6k 1.2× 1.6k 1.3× 297 0.3× 498 0.7× 191 3.9k
Shane M. Meehan United States 27 611 0.4× 1.4k 1.1× 601 0.5× 769 0.9× 548 0.8× 57 3.4k
Kota Takahashi Japan 35 1.3k 0.8× 340 0.3× 1.5k 1.3× 351 0.4× 1.1k 1.6× 199 4.3k
Jorge A. Velosa United States 32 1.8k 1.1× 912 0.7× 1.4k 1.2× 229 0.3× 679 1.0× 76 4.1k
Lutz T. Weber Germany 30 1.7k 1.0× 897 0.7× 456 0.4× 251 0.3× 281 0.4× 155 3.5k
R B Colvin United States 30 1.3k 0.8× 851 0.7× 1.6k 1.3× 1.8k 2.1× 200 0.3× 60 4.8k
B. Sis Canada 44 5.6k 3.5× 2.0k 1.6× 3.4k 2.9× 1.8k 2.0× 999 1.4× 97 7.3k

Countries citing papers authored by Ben Sprangers

Since Specialization
Citations

This map shows the geographic impact of Ben Sprangers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Sprangers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Sprangers more than expected).

Fields of papers citing papers by Ben Sprangers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Sprangers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Sprangers. The network helps show where Ben Sprangers may publish in the future.

Co-authorship network of co-authors of Ben Sprangers

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Sprangers. A scholar is included among the top collaborators of Ben Sprangers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Sprangers. Ben Sprangers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Niamh, David W. Johnson, Aisling Kelly, et al.. (2025). A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function. EClinicalMedicine. 82. 103101–103101.
2.
Sprangers, Ben, Alferso C Abrahams, Priyanka Koshy, et al.. (2024). Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney. Nephrology Dialysis Transplantation. 39(5). 888–892. 2 indexed citations
3.
Zhang, Hong, Dana V. Rizk, Vlado Perkovic, et al.. (2023). Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy. Kidney International. 105(1). 189–199. 62 indexed citations
4.
Sprangers, Ben, et al.. (2022). Lupus, DNA Methylation, and Air Pollution: A Malicious Triad. International Journal of Environmental Research and Public Health. 19(22). 15050–15050. 7 indexed citations
5.
Soebadi, Mohammad Ayodhia, Mieke Metzemaekers, Nele Berghmans, et al.. (2022). Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide. Clinical & Translational Immunology. 11(2). e1370–e1370. 2 indexed citations
6.
Sprangers, Ben, David E. Leaf, Camillo Porta, María José Soler, & Mark A. Perazella. (2022). Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury. Nature Reviews Nephrology. 18(12). 794–805. 31 indexed citations
7.
Arcolino, Fanny Oliveira, Sarah A. Hosgood, Jean Herman, et al.. (2022). De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells. American Journal of Transplantation. 22(12). 2791–2803. 7 indexed citations
8.
Loon, Elisabet Van, Baptiste Lamarthée, Henriëtte de Loor, et al.. (2022). Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney International. 102(1). 183–195. 15 indexed citations
9.
Rovin, Brad H., Sharon G. Adler, Elion Hoxha, et al.. (2021). Felzartamab in Patients with Anti-Phospholipase A2 Receptor Autoantibody Positive (Anti-PLA2R+) Membranous Nephropathy (MN): Interim Results from the M-PLACE Study. Journal of the American Society of Nephrology. 32(10S). 513–514. 1 indexed citations
10.
Jørgensen, Hanne Skou, Geert J. Behets, Bert Bammens, et al.. (2021). Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrology Dialysis Transplantation. 36(11). 2130–2139. 12 indexed citations
11.
Lin, Yuan, et al.. (2020). Donor Lymphocyte–Derived Natural Killer Cells Control MHC Class I–Negative Melanoma. Cancer Immunology Research. 8(6). 756–768. 4 indexed citations
12.
Adasme, Melissa F., Sebastian Salentin, V. Joachim Haupt, et al.. (2020). Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor. PLoS ONE. 15(5). e0233089–e0233089. 22 indexed citations
13.
Staels, Frederik, Albrecht Betrains, Peter Doubel, et al.. (2020). Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature. Frontiers in Immunology. 11. 575219–575219. 31 indexed citations
14.
Callemeyn, Jasper, Evelyne Lerut, Aleksandar Senev, et al.. (2020). Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. American Journal of Transplantation. 21(7). 2413–2423. 32 indexed citations
15.
Lin, Yuan, Omer Rutgeerts, Xavier Sagaert, et al.. (2019). Solid Tumor–Induced Immune Regulation Alters the GvHD/GvT Paradigm after Allogenic Bone Marrow Transplantation. Cancer Research. 79(10). 2709–2721. 8 indexed citations
16.
Poesen, Ruben, Pieter Evenepoel, Henriëtte de Loor, et al.. (2016). The influence of renal transplantation on retained microbial–human co-metabolites. Nephrology Dialysis Transplantation. 31(10). 1721–1729. 37 indexed citations
17.
Heylen, Line, Johan Maertens, Bert Bammens, et al.. (2015). Invasive aspergillosis after kidney transplantation: a monocentric retrospective experience. Lirias (KU Leuven). 1 indexed citations
18.
Evenepoel, P., Kristien Daenen, Bert Bammens, et al.. (2015). Microscopic nephrocalcinosis in chronic kidney disease patients. Nephrology Dialysis Transplantation. 30(5). 843–848. 19 indexed citations
19.
Claes, Kathleen, Bert Bammens, Dirk Kuypers, et al.. (2014). Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation. Nephrology Dialysis Transplantation. 29(10). 1965–1972. 4 indexed citations
20.
Sprangers, Ben, Neal B. West, Robert Brenner, & Cynthia L. Bethea. (1990). Regulation and Localization of Estrogen and Progestin Receptors in the Pituitary of Steroid-Treated Monkeys*. Endocrinology. 126(2). 1133–1142. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026